相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The anti-diabetic drug metformin inhibits vascular endothelial growth factor expression via the mammalian target of rapamycin complex 1/hypoxia-inducible factor-1α signaling pathway in ELT-3 cells
Mad Tadakawa et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Metformin Inhibits Angiogenesis Induced by Interaction of Hepatocellular Carcinoma with Hepatic Stellate Cells
Hongmei Qu et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Paradoxic effects of metformin on endothelial cells and angiogenesis
Katiuscia Dallaglio et al.
CARCINOGENESIS (2014)
Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment
Gianluigi Giannelli et al.
GUT (2014)
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Metformin and risk of hepatocellular carcinoma: are statins the missing link?
Siddharth Singh et al.
GUT (2013)
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
Hsiao-Ping Chen et al.
GUT (2013)
Metabolic Syndrome Increases the Risk of Primary Liver Cancer in the United States: A Study in the SEER-Medicare Database
Tania M. Welzel et al.
HEPATOLOGY (2011)
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Brad Q. Starley et al.
HEPATOLOGY (2010)
分享论文
